Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Cemiplimab Rwlc 350 Mg/7 Ml Sol (CDM 7330404) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 26, 2026 , from http://ppman.hank.ai/transparency/procedure/7330404/by-state?code_type=CDM
“Cemiplimab Rwlc 350 Mg/7 Ml Sol (CDM 7330404) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/7330404/by-state?code_type=CDM. Accessed
October 26, 2026 .
“Cemiplimab Rwlc 350 Mg/7 Ml Sol (CDM 7330404) by State,” HANK Price Transparency ,
accessed October 26, 2026 ,
http://ppman.hank.ai/transparency/procedure/7330404/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
7330404 — Cemiplimab Rwlc 350 Mg/7 Ml Sol
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$25,027
National median
$16,397 – $25,979
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 7330404 (CDM), with interquartile range
State Median p25 p75
CO $25,027 $16,397 $25,979